Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

1.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

1.4K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancer.

Science immunology·2026
Same author

[A new nomenclature for natural killer cells].

Medecine sciences : M/S·2026
Same author

NK cells promote cardiac cell death and regulate myelopoiesis in myocardial infarction.

Nature communications·2026
Same author

Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

Science immunology·2026
Same author

Bringing natural killer cells to the clinic: Opportunities beyond cancer.

The Journal of experimental medicine·2025
Same author

Innate lymphoid cells originate from fetal liver-derived tissue-resident progenitors.

Science immunology·2025

Related Experiment Video

Updated: Jul 2, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.1K

Natural killer cell therapies.

Eric Vivier1,2,3,4, Lucas Rebuffet5, Emilie Narni-Mancinelli5

  • 1Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. vivier@ciml.univ-mrs.fr.

Nature
|February 21, 2024
PubMed
Summary

Natural killer (NK) cells are innate immune lymphocytes that target distressed cells like tumors and virus-infected cells. Therapies harnessing NK cell immunity are advancing through clinical trials for cancer treatment.

More Related Videos

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

5.6K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

699

Related Experiment Videos

Last Updated: Jul 2, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.1K
Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

5.6K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

699

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Natural killer (NK) cells are crucial lymphocytes within the innate immune system.
  • NK cells possess the unique ability to identify and eliminate distressed cells, including cancerous and virally infected cells.
  • They play a dual role in immunity by directly attacking targets and modulating broader immune responses.

Purpose of the Study:

  • To provide a comprehensive overview of human NK cell biology.
  • To elucidate the critical role of NK cells in anti-cancer immunity.
  • To analyze current and emerging therapeutic strategies that leverage NK cell functions.

Main Methods:

  • Review of current scientific literature on NK cell biology and function.
  • Analysis of therapeutic approaches involving NK cells, including immune checkpoint inhibitors and NK cell engagers.
  • Examination of adoptive NK cell transfer strategies (preactivated, genetically modified, autologous, and allogeneic).

Main Results:

  • NK cells are versatile immune cells with direct cytotoxic functions and regulatory roles in multicellular immune responses.
  • NK cell-mediated immunity is a significant factor in controlling tumor progression.
  • Various therapeutic strategies are in development, showing promise for cancer immunotherapy.

Conclusions:

  • Understanding NK cell complexity is key to developing effective cancer immunotherapies.
  • Harnessing NK cell activity through novel therapeutic modalities offers a promising avenue for cancer treatment.
  • Ongoing research and clinical trials are vital for advancing NK cell-based therapies.